mRNA therapy (Moderna/Seattle Children's Research Institute)

N/A

Report date: 2025/01/26 15:32:17

Base Information

Drug NamemRNA therapy (Moderna/Seattle Children's Research Institute)
Drug Alias NameFactor VIII inhibitors (Moderna/Seattle Children’s Research Institute)mRNA encoding humanized anti-CD3 mAb lipid nanoparticle (Moderna/Seattle Children's Research Institute)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedSmall molecules > Nucleosides and nucleotide derivtives > OligonucleotideSmall molecules > Lipid
Mechanisms of ActionT cell surface glycoprotein CD3 inhibitorsCoagulation factor VIII inhibitors
TargetsT cell surface glycoprotein CD3Coagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesModerna Inc
China Registration ClassN/A

Develop Information

Active CompaniesModerna IncSeattle Children'S Hospital
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A